Psychedelics Research Recap May 2021
Psychedelic research in May saw the MAPS MDMA study data, psychedelics and genes, and many psychedelic center studies.
Research
Research Briefing: Your genes and psychedelics
In the Research Briefing of May 27th 1) The intensity of an LSD experience as predicted by your genes 2) A brain on psilocybin becomes less segregated 3) Bringing people from different worlds together through ayahuasca
Research Briefing: The most complete picture of our brain on psychedelics
In the Research Briefing of May 19th 1) The most complete picture we have of our brains on LSD 2) Psychedelics may help us explore consciousness, we should also be aware of what we can’t explain
Research Briefing: MDMA versus PTSD and Psychedelics versus COVID
In the Research Briefing of May 12th: 1) MAPS reports a successful trial of MDMA-assisted therapy for PTSD 2) Moving past mysticism in psychedelic research 3) Psychedelic users appear to be more resilient in the face of Covid
Long term experience with psychedelics and empathogens
Claude Weill argues that the successful integration of psychedelics and empathogenic substances can lead to long-term meaning and fulfilment.
Research Briefing: In awe of molecular tools
In the Research Briefing of May 6th: 1) A new biosensor helps identify which molecules are hallucinogenic 2) Microdosing and awe, experiencing the sublime on psilocybin 3) Large meta-analysis finds esketamine lowers depression scores
Psychedelics Research Recap April 2021
Psychedelic research in April pitted psychedelics against SSRIs, gave mice a break from tripping, and found new psychedelics. As we’re awaiting the full results of the MAPS Phase III MDMA trial data, let’s look back at the research of last month.
Psychedelics Research Links May 2021
This is all the other psychedelic research that came out in May 2021.
Top 12 Articles on Ketamine for Mental Health
The papers you must have read on the use of ketamine for mental health, from depression to suicidal ideation. This selection of research on ketamine for mental health will explore its promise in treating not only depression but also the positive effects on suicidal ideation, addiction, and further symptoms of mental health disorders.
Research Briefing: Hallucinogenic effects not necessary?
In the Research Briefing of April 21st: 1) Psilocybin pitted against antidepressant and wins on many accounts 2) What if the anti-depressant and hallucinogenic effects of psychedelics are independent?